Uncategorized

Escalating Health Issues and API The Active Pharmaceutical Ingredients (API) market is increasing constantly, as it is a crucial active raw material used in medicines to determine their strength, dosage and effectiveness, which is important in the treatment of chronic diseases, including cardiovascular disorders, diabetes, and cancer. And the stats regarding the rise in these types

India and China are dominating the API industry globally, driven by several factors, including low labour costs, a highly skilled workforce, strong infrastructure, numerous USFDA/EMA-approved plants, and government-friendly policies. For instance, India’s investment commitment (i.e., ₹3,938.5 crore) has exceeded this figure and reached ₹4,570 crore in 2025, specifically in this sector. These numbers not only

Desvenlafaxine succinate market strengthens as FDA approvals support broader antidepressant therapy adoption. Industry Overview Desvenlafaxine succinate market is growing at a CAGR of 2.8% during the forecast period (2025-2035). Desvenlafaxine Succinate is a serotonin-norepinephrine reuptake inhibitor (SNRI), given mostly for the treatment of major depressive disorder (MDD) and occasionally for anxiety-related ailments. Sold under brand

Dr. Reddy’s Laboratories has officially received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (US FDA) for the Active Pharmaceutical Ingredient (API) manufacturing facility in Middleburgh, New York. The report has been issued after a Good Manufacturing Practice (GMP) inspection, which has been categorized as Voluntary Action Indicated (VAI), and the

Increasing infectious disease prevalence, growth of generic formulations, and growing healthcare availability are fueling the Amoxicillin Sodium market. Industry Overview Amoxicillin sodium market is growing at a CAGR of 1.9% during the forecast period (2025-2035). This expansion is driven by growing bacterial infections, broader access to healthcare globally, and the prevalent trend towards affordable generic

Zydus Lifesciences has reached a significant regulatory milestone as the US Food and Drug Administration (FDA) has given a No Action Indicated (NAI) status to its Active Pharmaceutical Ingredient (API) manufacturing plant in Ankleshwar, Gujarat, highlighting the company’s dedication to manufacturing excellence and quality assurance globally. US FDA Surveillance Inspection & Outcome From March 10

Tamsulosin Hydrochloride Market finds new growth paths through off-label prescribing for female urinary retention and chronic pelvic pain. Industry Overview Tamsulosin hydrochloride market is growing at a CAGR of 6.3% during the forecast period (2025-2035). The Tamsulosin Hydrochloride Market is witnessing substantial growth following the increasing incidence of Benign Prostatic Hyperplasia (BPH), the growing geriatric

Oxcarbazepine market is gaining momentum amid increasing epilepsy prevalence, generic drug approvals, and growing neurological disorder diagnoses globally. Industry Overview Oxcarbazepine market was valued at a CAGR of 4.2% during the forecast period (2025-2035). Oxcarbazepine, a carbamazepine structural derivative, is mainly applied in treating epilepsy and seizures. Its enhanced safety profile and fewer drug interactions

The rising burden of cardiovascular disease is turning the spotlight on intravenous vasodilators, propelling the Nicardipine Hydrochloride Market forward. Industry Overview Nicardipine hydrochloride market Nicardipine Hydrochloride is a calcium channel blocker mainly used in the treatment of angina and high blood pressure, and its need is rising internationally owing to the growing incidence of cardiovascular